- Home
- HONE vs CRMD Comparison
HONE vs CRMD Comparison
Compare HONE & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- CRMD
- Stock Information
- Founded
- HONE 1917
- CRMD 2006
- Country
- HONE United States
- CRMD United States
- Employees
- HONE N/A
- CRMD N/A
- Industry
- HONE Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- CRMD Health Care
- Exchange
- HONE Nasdaq
- CRMD Nasdaq
- Market Cap
- HONE 529.8M
- CRMD 626.8M
- IPO Year
- HONE 2016
- CRMD 2010
- Fundamental
- Price
- HONE $12.96
- CRMD $10.33
- Analyst Decision
- HONE Hold
- CRMD Strong Buy
- Analyst Count
- HONE 1
- CRMD 5
- Target Price
- HONE $13.00
- CRMD $15.20
- AVG Volume (30 Days)
- HONE 201.6K
- CRMD 1.6M
- Earning Date
- HONE 10-24-2024
- CRMD 10-30-2024
- Dividend Yield
- HONE 2.45%
- CRMD N/A
- EPS Growth
- HONE N/A
- CRMD N/A
- EPS
- HONE 0.27
- CRMD N/A
- Revenue
- HONE $158,656,000.00
- CRMD $12,262,234.00
- Revenue This Year
- HONE N/A
- CRMD N/A
- Revenue Next Year
- HONE $0.86
- CRMD $277.75
- P/E Ratio
- HONE $47.59
- CRMD N/A
- Revenue Growth
- HONE N/A
- CRMD 41184.20
- 52 Week Low
- HONE $9.16
- CRMD $2.89
- 52 Week High
- HONE $14.00
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- HONE 52.61
- CRMD 47.20
- Support Level
- HONE $12.91
- CRMD $10.16
- Resistance Level
- HONE $13.23
- CRMD $11.41
- Average True Range (ATR)
- HONE 0.39
- CRMD 0.73
- MACD
- HONE 0.02
- CRMD -0.18
- Stochastic Oscillator
- HONE 70.45
- CRMD 31.00
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in each of Boston, Massachusetts and Providence, Rhode Island.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.